<div><p>The trimeric envelope (Env) spike is the focus of vaccine design efforts aimed at generating broadly neutralizing antibodies (bNAbs) to protect against HIV-1 infection. Three recent developments have facilitated a thorough investigation of the antigenic structure of the Env trimer: 1) the isolation of many bNAbs against multiple different epitopes; 2) the generation of a soluble trimer mimic, BG505 SOSIP.664 gp140, that expresses most bNAb epitopes; 3) facile binding assays involving the oriented immobilization of tagged trimers. Using these tools, we generated an antigenic map of the trimer by antibody cross-competition. Our analysis delineates three well-defined epitope clusters (CD4 binding site, quaternary V1V2 and Asn332-center...
Stabilized HIV-1 envelope glycoproteins (Env) that resemble the native Env are utilized in vaccinati...
Inducing broad spectrum neutralizing antibodies against challenging pathogens such as HIV-1 is a maj...
Inducing broad spectrum neutralizing antibodies against challenging pathogens such as HIV-1 is a maj...
The trimeric envelope (Env) spike is the focus of vaccine design efforts aimed at generating broadly...
International audienceThe recent identification of three broadly neutralizing antibodies (bnAbs) aga...
International audienceThe recent identification of three broadly neutralizing antibodies (bnAbs) aga...
International audienceThe recent identification of three broadly neutralizing antibodies (bnAbs) aga...
International audienceThe recent identification of three broadly neutralizing antibodies (bnAbs) aga...
A desirable but as yet unachieved property of a human immunodeficiency virus type 1 (HIV-1) vaccine ...
<div><p>A desirable but as yet unachieved property of a human immunodeficiency virus type 1 (HIV-1) ...
The recent identification of three broadly neutralizing antibodies (bnAbs) against gp120–gp41 interf...
A major goal for HIV-1 vaccine development is an ability to elicit strong and durable broadly neutra...
The HIV-1 envelope (Env) glycoprotein binds to host cell receptors to mediate membrane fusion. The p...
The HIV-1 envelope (Env) glycoprotein binds to host cell receptors to mediate membrane fusion. The p...
The trimeric envelope glycoproteins (Env) on the surface of HIV-1 virions are the targets for neutra...
Stabilized HIV-1 envelope glycoproteins (Env) that resemble the native Env are utilized in vaccinati...
Inducing broad spectrum neutralizing antibodies against challenging pathogens such as HIV-1 is a maj...
Inducing broad spectrum neutralizing antibodies against challenging pathogens such as HIV-1 is a maj...
The trimeric envelope (Env) spike is the focus of vaccine design efforts aimed at generating broadly...
International audienceThe recent identification of three broadly neutralizing antibodies (bnAbs) aga...
International audienceThe recent identification of three broadly neutralizing antibodies (bnAbs) aga...
International audienceThe recent identification of three broadly neutralizing antibodies (bnAbs) aga...
International audienceThe recent identification of three broadly neutralizing antibodies (bnAbs) aga...
A desirable but as yet unachieved property of a human immunodeficiency virus type 1 (HIV-1) vaccine ...
<div><p>A desirable but as yet unachieved property of a human immunodeficiency virus type 1 (HIV-1) ...
The recent identification of three broadly neutralizing antibodies (bnAbs) against gp120–gp41 interf...
A major goal for HIV-1 vaccine development is an ability to elicit strong and durable broadly neutra...
The HIV-1 envelope (Env) glycoprotein binds to host cell receptors to mediate membrane fusion. The p...
The HIV-1 envelope (Env) glycoprotein binds to host cell receptors to mediate membrane fusion. The p...
The trimeric envelope glycoproteins (Env) on the surface of HIV-1 virions are the targets for neutra...
Stabilized HIV-1 envelope glycoproteins (Env) that resemble the native Env are utilized in vaccinati...
Inducing broad spectrum neutralizing antibodies against challenging pathogens such as HIV-1 is a maj...
Inducing broad spectrum neutralizing antibodies against challenging pathogens such as HIV-1 is a maj...